跳至主要内容
临床试验/NCT01305031
NCT01305031已完成不适用

Resuscitation of Late-preterm Infants by Using Room Air or 100% Oxygen

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70
试验地点
1
主要终点
oxidative stress status

研究概览

简要总结

In this randomized control trial, the investigators hypothesize that late-preterm infants resuscitated with a "low oxygen delivery" strategy (initiation of resuscitation with room air) will result in a significant reduction in oxidant stress without any harmful clinical effects.

详细描述

The delivery of high oxygen concentrations leads to the production of free radicals that can injure many organ systems. Some studies have shown that resuscitation of term newborn infants with room air were safe and of great benefit. A static room air, however, may be inappropriate for resuscitation of preterm infants. The number of late-preterm infants has increased in recent years, which represent approximately 70% of all preterm infants. Our study will evaluate the safety and efficacy of using room air during resuscitation of late-preterm infants and whether this will avoid oxidative stress derived damage and improve outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
34 Weeks 至 37 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • inborn infant
  • gestation 34 weeks to 36 weeks 6 days

排除标准

  • known chromosomal or congenital anomalies

结局指标

主要结局

oxidative stress status

时间窗: 7 days

oxygen saturations

时间窗: 10 min

次要结局

  • Necrotizing Enterocolitis(28 days)
  • Retinopathy of prematurity(28 days)
  • Days on oxygen(28 days)
  • Intracranial hemorrhage(28 days)
  • Days on conventional ventilation(28 days)
  • Days on nasal canula(28 days)
  • Pneumothorax(28 days)
  • Days on high frequency ventilation(28 days)
  • Oxygen requirement(At 36 weeks adjusted age)
  • Hypoxic ischemic encephalopathy(28 days)
  • Patent ductus arteriosus(28 days)
  • Death(28 days)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhangbin Yu

Director

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验